Tryptophan 46 is a site for ethanol and ivermectin action in P2X4 receptors

Maya Popova1, James Trudell, Kaixun Li

  • 1Alcohol and Brain Research Laboratories, Titus Family Department of Clinical Pharmacy & Pharmaceutical Economics and Policy, School of Pharmacy, University of Southern California, 1985 Zonal Avenue, Los Angeles, CA, 90089, USA.

Insights

Ivermectin (IVM) and ethanol interact with specific sites on alcohol-sensitive P2X4 receptors (P2X4Rs). Mutating key amino acids in these sites alters receptor responses, suggesting a potential therapeutic target for alcohol use disorders.

Area of Science:

  • Neuropharmacology
  • Molecular Biology
  • Addiction Research

Background:

  • ATP-gated purinergic P2X4 receptors (P2X4Rs) are highly sensitive to alcohol.
  • Ivermectin (IVM) antagonizes ethanol's effects on P2X4Rs and reduces alcohol intake in mice.
  • Previous molecular modeling identified a potential binding pocket for ethanol and IVM.

Purpose of the Study:

  • To investigate the role of tryptophan at position 46 (Trp46) in P2X4R modulation by ethanol and IVM.
  • To explore the involvement of other residues, including tyrosine at position 42 (Tyr42), in the receptor's response to these compounds.

Main Methods:

  • Site-directed mutagenesis of Trp46 and other residues in the P2X4R.
  • Functional characterization of mutant receptors using Xenopus oocyte expression and two-electrode voltage clamp.
  • Molecular modeling based on zebrafish P2X4R crystal structures.

Main Results:

  • Mutations at Trp46 altered ethanol inhibition and switched IVM from potentiation to inhibition.
  • Simultaneous mutations at Trp46 and Met336 yielded similar functional changes.
  • A new molecular model highlighted Tyr42, and experimental validation supported its role.

Conclusions:

  • The identified amino acid residues (42, 46, 331, 336) form a critical pocket for ethanol and IVM action on P2X4Rs.
  • This pocket represents a promising target for developing novel medications for alcohol use disorders.

Related Concept Videos

Sedatives and Hypnotics Drugs: Miscellaneous Agents01:17

Sedatives and Hypnotics Drugs: Miscellaneous Agents

Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Repressible Operon: trp Operon01:21

Repressible Operon: trp Operon

The trp operon in Escherichia coli exemplifies a repressible operon. It regulates the synthesis of tryptophan through repressor-mediated transcriptional control and attenuation. This dual regulatory mechanism ensures tryptophan biosynthesis occurs only when needed, conserving cellular resources.Structure of the trp OperonThe trp operon consists of five structural genes (trpE, trpD, trpC, trpB, and trpA) that encode enzymes for tryptophan biosynthesis. These genes are transcribed as a single...
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
Drugs Affecting GI Tract Motility: Serotonin Receptor Agonists01:23

Drugs Affecting GI Tract Motility: Serotonin Receptor Agonists

Serotonin, a crucial neurotransmitter synthesized by enterochromaffin cells, plays a cardinal role in regulating gastrointestinal (GI) motility. With over 90% of the body's total serotonin in the GI tract, its influence on digestive processes is profound. Serotonin is swiftly released upon various stimuli, such as food boluses or certain drugs, triggering intrinsic sensory neurons in the myenteric plexus and extrinsic vagal and spinal sensory neurons. This leads to the activation of the...
Anthelminthic Agents01:15

Anthelminthic Agents

Anthelmintic drugs differ significantly from antiparasitic therapies targeting protozoa, primarily due to differences in parasite biology. Whereas most protozoal treatments act on proliferating cells, anthelmintics are typically directed against mature, nonproliferative helminths. The therapeutic approach considers the helminth's reliance on neuromuscular coordination, glucose metabolism, and microtubular integrity for survival, reproduction, and localization within the host. Most anthelmintics...
Transcription Attenuation in Prokaryotes02:42

Transcription Attenuation in Prokaryotes

Transcriptional attenuation occurs when RNA transcription is prematurely terminated due to the formation of a terminator mRNA hairpin structure.  Bacteria use these hairpins to regulate the transcription process and control the synthesis of several amino acids including histidine, lysine, threonine, and phenylalanine. Transcription attenuation takes place in the non-coding regions of mRNA.
There are several different mechanisms used to attenuate transcription. In ribosome mediated...